KRTL Holding Group, Inc. Advances Methylene Blue Initiative Through Strategic Partnership with Aura Nootropics

KRTL Holding Group, Inc. (“KRTL Holding” or the “Company”) announced today that its subsidiary, KRTL Biotech Inc. (“KRTL Biotech”), has entered into a strategic partnership with Aura Nootropics, Inc. (“AURA”), marking the next phase in the Company’s ongoing methylene blue initiative.

Building on the Parties’ initial collaboration, the newly executed agreements establish a formal framework for the development, commercialization, and international expansion of consumer products incorporating methylene blue (“MB Products”), beginning in Thailand.

The partnership is structured through a coordinated equity and collaboration framework, under which KRTL Biotech will obtain a minority ownership position in AURA while also participating as a strategic partner in advancing MB Products. The agreements are intended to align long-term interests and establish a scalable foundation for continued development.

This development represents a continuation of the Company’s previously announced methylene blue initiative, as KRTL Biotech advances from initial collaboration efforts into a formalized partnership and defined pathway toward potential product development and commercialization.

Through this partnership, the Parties are moving forward with a more structured approach to evaluating product opportunities, combining KRTL Biotech’s access to a proprietary methylene blue formulation and regulatory positioning with AURA’s established network in Thailand and experience in product development, branding, and market access.

The Company indicated that initial efforts are expected to begin in Thailand, serving as a strategic entry point for MB Product development and commercialization, with broader regional opportunities to be evaluated as the collaboration progresses.

Leadership of KRTL Biotech Inc. stated, “This partnership represents a natural progression in advancing our methylene blue platform. By formalizing our relationship with AURA through both equity participation and a structured collaboration framework, we are creating a disciplined process to evaluate product concepts, regulatory requirements, and potential commercial opportunities in selected international markets. ”

KRTL Holding stated that this milestone reflects continued execution of its broader strategy to align its scientific capabilities with scalable commercial platforms across biotechnology, pharmaceuticals, and emerging consumer health sectors. Any products developed under the partnership would be subject to applicable regulatory, formulation, labeling, import/export, and commercialization requirements in the relevant jurisdictions.

About KRTL Holding Group Inc.

KRTL Holding Group Inc. is focused on advancing innovation across biotechnology, pharmaceuticals, and emerging healthcare platforms through its subsidiaries, including KRTL Biotech Inc. and KRTL International.

About KRTL Biotech Inc.

KRTL Biotech Inc. is focused on the development and commercialization of specialized compounds and biotechnology-driven solutions, with an emphasis on regulatory-aligned applications across pharmaceutical, nutraceutical, and consumer markets.

About Aura Nootropics, Inc.

Aura Nootropics, Inc. is focused on the development, branding, and commercialization of consumer products within the nootropic and wellness sectors.

For more information:

www.krtlholding.com | www.krtl-icc.com | www.krtlbiotech.com | www.auranootropics.com

Forward-Looking Statements

This press release contains statements and information that, to the extent that they are not historical fact, may constitute  “forward-looking statements” within the meaning of applicable securities legislation. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as “anticipates,” “will,” “believes,” “plans,” “expects,” “intends,” “projects,” “estimates,” “future,” and “opportunity” and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments and acquisitions; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law.